![Beyond the linear quadratic model: intraoperative radiotherapy and normal tissue tolerance - Emami - Translational Cancer Research Beyond the linear quadratic model: intraoperative radiotherapy and normal tissue tolerance - Emami - Translational Cancer Research](https://cdn.amegroups.cn/journals/pbpc/files/journals/3/articles/4270/public/4270-PB6-R1.png/w300)
Beyond the linear quadratic model: intraoperative radiotherapy and normal tissue tolerance - Emami - Translational Cancer Research
![Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial - ScienceDirect Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0360301620347374-gr1.jpg)
Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial - ScienceDirect
![Table 3 from Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost. | Semantic Scholar Table 3 from Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9c99db99b7f59c08f990fc39059f7d064311c35e/7-Table3-1.png)
Table 3 from Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost. | Semantic Scholar
![Table 1 from Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost. | Semantic Scholar Table 1 from Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9c99db99b7f59c08f990fc39059f7d064311c35e/3-Table1-1.png)
Table 1 from Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost. | Semantic Scholar
The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies
![Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials - ScienceDirect Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0167814017326877-fx1.jpg)
Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials - ScienceDirect
Optimization of Carbon Ion Treatment Plans by Integrating Tissue Specific α/β-Values for Patients with Non-Resectable Pancreatic Cancer | PLOS ONE
![Beyond the linear quadratic model: intraoperative radiotherapy and normal tissue tolerance - Emami - Translational Cancer Research Beyond the linear quadratic model: intraoperative radiotherapy and normal tissue tolerance - Emami - Translational Cancer Research](https://cdn.amegroups.cn/journals/pbpc/files/journals/3/articles/4270/public/4270-PB8-R1.png/w300)
Beyond the linear quadratic model: intraoperative radiotherapy and normal tissue tolerance - Emami - Translational Cancer Research
![The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies | Radiation Oncology | Full Text The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies | Radiation Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13014-018-1040-z/MediaObjects/13014_2018_1040_Fig3_HTML.gif)
The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies | Radiation Oncology | Full Text
![Table 3 from Interferon (Alpha, Beta and Omega) Receptor 2 Is a Prognostic Biomarker for Lung Cancer | Semantic Scholar Table 3 from Interferon (Alpha, Beta and Omega) Receptor 2 Is a Prognostic Biomarker for Lung Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5fae06ac110382ab9150c155c1be2198b363a159/6-Table2-1.png)
Table 3 from Interferon (Alpha, Beta and Omega) Receptor 2 Is a Prognostic Biomarker for Lung Cancer | Semantic Scholar
![PDF) Assessment of the alpha/beta ratio of the optic pathway to adjust hypofractionated stereotactic radiosurgery regimens for perioptic lesions PDF) Assessment of the alpha/beta ratio of the optic pathway to adjust hypofractionated stereotactic radiosurgery regimens for perioptic lesions](https://www.researchgate.net/profile/Herwin-Speckter/publication/335102529/figure/tbl1/AS:798392582152192@1567363033175/Q7-fractionation-courses-with-doses-that-have-the-same-biological-effect-on-the-optic_Q320.jpg)